Brind.

Intellia Therapeutics received a share upgrade from William Blair, while Bank of America reiterated a neutral rating on June 17, 2026.

1 report, 1 independent Updated Jun 17

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Intellia Therapeutics William P. Blair Bank of America

Keep exploring

The entities involved

Intellia Therapeutics
It is a biotechnology company developing biopharmaceuticals using a CRISPR gene editing system.

Nothing else this week.
William P. Blair
American astrophysicist
- Watsco reported margin impacts due to subdued international sales in Mexico, with analysts questioning volume trends.Sun 06:23
Bank of America
American multinational banking and financial services corporation
- Goldman Sachs, Morgan Stanley, JPMorgan Chase, and Bank of America are competing in the global investment banking sector.Mon 17:24
- Both Bank of America and Deloitte have addressed current treasury management trends.Mon 14:26

Related events

Coverage

Newest first; wire copies grouped

Jun 17dailypolitical.com